Stock Report

Download full stock data and analysis for free Last Updated: 09-May-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Novelix Pharmaceuticals Ltd.

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 536565

₹54.55

₹0.00 (0.00%)

As on 08-May-2026IST

Market cap

info icon

₹115 Cr

Revenue (TTM)

info icon

₹128 Cr

P/E Ratio

info icon

63

P/B Ratio

info icon

2.3

Div. Yield

info icon

0 %

Novelix Pharmaceuticals Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio
BSE
BSE

Stock Range

Today’s Range

Low: 53.02 High: 58.70

52 Week Range

Low: 27.94 High: 70.16

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹2 Cr

  • ROEROE information

    0.7 %

  • ROCEROCE information

    1 %

  • Industry P/EIndustry P/E information

    32.14

  • EV/EBITDAEV/EBITDA information

    46.2

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹23.3

  • EPSEPS information

    ₹1.2

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    21,085,000

10 Years Aggregate

CFO

₹-12.55 Cr

EBITDA

₹-7.43 Cr

Net Profit

₹-6.41 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Novelix Pharmaceuticals
-12.9 8.5 -14.4 105.0 72.6 41.4 22.4
BSE Healthcare
7.1 11.7 10.9 10.9 26.2 14.1 11.7
As on 08-May-2026
Company
2025
2024
2023
2022
2021
2020
Novelix Pharmaceuticals
158.6 104.8 8.7 54.5 8.4 118.8
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in (₹ Cr)

Annual

*All values are in (₹ Cr)

Annual

*All values are in (₹ Cr)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Novelix Pharmaceuticals
54.6 115.0 128.0 1.8 1.8 8.5 63 2.3
Ajanta Pharma
3,035.0 37,883.0 5,452.9 1,056.0 22.4 23.9 35.9 8.4
Astrazeneca Pharma
8,493.0 21,223.1 2,177.5 200.9 11.3 26.5 105.6 25.5
Caplin Point Lab
1,856.3 14,118.0 2,089.5 622.0 31.3 20.4 23 4.2
CORONA Remedies
1,712.3 10,471.5 1,196.4 149.4 -- 27.5 70.1 14.9
Eris Lifesciences
1,386.1 19,212.4 3,078.2 469.4 26.4 14.9 44.5 5.3
JB Chemicals
2,149.8 34,550.6 4,193.0 753.8 22.7 20.8 45.8 8.6
Pfizer
4,818.8 22,009.5 2,482.3 853.6 33.7 18.9 25.8 5.5
Procter & Gamble Health
5,355.0 8,882.9 1,348.5 293.5 28.1 50.7 30.3 12.7
Strides Pharma
1,156.9 10,653.8 4,725.6 528.7 14.9 20.7 20.8 3.6

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Novelix Pharmaceuticals

Other financial service activities, except insurance and pension funding activities

  • Incorporated

    1994

  • Chairman

    --

  • Managing Director

    --

  • Headquarters

    Hyderabad, Telangana

  • Website

    www.trimurthidrugs.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Novelix Pharmaceuticals

The share price of Novelix Pharmaceuticals Ltd is ₹54.55 (BSE) as of 08-May-2026 IST. Novelix Pharmaceuticals Ltd has given a return of 72.65% in the last 3 years.

The P/E ratio of Novelix Pharmaceuticals Ltd is 62.99 times as on 08-May-2026, a 96 premium to its peers’ median range of 32.14 times.
The P/B ratio of Novelix Pharmaceuticals Ltd is 2.34 times as on 08-May-2026, a 51 discount to its peers’ median range of 4.76 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
313.43
1.51
2024
1,332.56
1.89
2023
0.00
1.01
2022
0.00
0.97
2021
0.00
0.80

The 52-week high and low of Novelix Pharmaceuticals Ltd are Rs 70.16 and Rs 27.94 as of 09-May-2026.

Novelix Pharmaceuticals Ltd has a market capitalisation of ₹ 115 Cr as on 08-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Novelix Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.